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Previewsforgiven for imagining that inhibition of
these signaling events would increase
the pathogenic potential of S. aureus,
and, in many strains, that is indeed what
happens. But Kretschmer et al. (2010)
have demonstrated that PSMs activate
cells by signaling specifically through
FPR2/ALX, causing influx of neutrophils
at the site of infection, where they are
then lysed, presumably by higher local
concentrations of PSMs. How S. aureus
ensures appropriate expression of these
antagonists relative to PSMs remains to
be elucidated. It is noteworthy that
FPR2/ALX appears to play no part in
PSM cytotoxicity (Kretschmer et al.,
2010). Clearly, the success of CA-MRSA
strains is linked to their ability to produce
relatively large concentrations of PSMs,
which, in turn, have the ability to attract
phagocytic neutrophils (Wang et al.,
2007; Kretschmer et al., 2010). However,
these cells are unable to destroy the
invading S. aureus and eradicate the
infection because of the other edge to
this PSM sword, namely a powerful cyto-
lytic activity that can destroy those
incoming immune cells. Associated with
this activity is extensive tissue destruc-424 Cell Host & Microbe 7, June 17, 2010 ª2tion, which is presumably advantageous
to S. aureus.
These interesting findings need to be
viewed in a wider context of recognition
of S. aureus by the immune system. The
human host employs an array of sensor
mechanisms in order to recognize a spec-
trum of bacterial components. In addition
to being recognized by formyl peptide
receptors, PSMs (albeit from Staphylo-
coccus epidermidis) have been reported
to activate human cells through Toll-like
receptors 2 (Hajjar et al., 2001). It thus
seems possible that the pathogen manip-
ulates multiple host cell signaling path-
ways with a single molecule to mediate
CA-MRSA disease. It is through such
understanding of the dynamics of host-
pathogen interactions that we may be
able to develop novel strategies for inter-
vention and treatment of debilitating
bacterial diseases such as CA-MRSA.REFERENCES
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Viruses are perfect opportunists that have evolved to modify numerous cellular processes in order to
complete their replication cycle in the host cell. An article by Reggiori and coworkers in this issue of Cell
Host & Microbe reveals how coronaviruses can divert a cellular quality control pathway that normally func-
tions in degradation of mis-folded proteins to replicate the viral genome.Asobligatory intracellularparasites,viruses
mayuse every component andmechanism
of the cell in order to produce infectious
progeny. Virtually every step of a viral repli-
cation cycle occurs in close association
with cellularmembranes, the cytoskeleton,
membrane trafficking, or signaling path-
ways. Given their total dependence on
host cells, it is not surprising that viruseshaveevolved tomodifycells to their benefit.
Particularly interesting in this respect is that
viruses may exploit the cellular defense
mechanisms that are induced in response
to infection and that are aimed at destroy-
ing invading pathogens.
Viruses with a RNA genome of plus-
stranded polarity without exception repli-
cate their RNA in the host cytoplasm.For those that have been studied at the
ultrastructural level, genome replication
seems to be accompanied by the induc-
tion of membrane proliferations. These
membranes are thought to serve as scaf-
folds for the viral replication translation
complexes (RTCs) and to protect newly
synthesized viral RNA (Miller and Krijnse-
Locker, 2008). At the ultrastructural level,
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Previewsa common feature of these virally induced
membranes is their double-membrane
appearance and close association with
the endoplasmic reticulum (ER) (Miller
and Krijnse-Locker, 2008).
Because of morphological similarity to
autophagosomes, it has been postulated
that positive-strand RNA viruses may
divert the autophagy machinery to induce
double-membrane vesicles (DMVs). Au-
tophagy is a cellular process aimed at de-
grading cellular cytoplasmic compounds
and can be enhanced by stressors such
as starvation, oxidative stress, or path-
ogen infection. Autophagy starts with the
formation of a crescent-shaped double
membrane that matures into a double-
membrane vesicle, hence the proposed
similarity to virally induced DMVs. Ulti-
mately, the autophagosome fuses with
lysosomes, resulting in the degradation
of its engulfed material by lysosomal
enzymes. More than 30 autophagy-
related genes (atgs) have been identified
in yeast, many of which are conserved in
mammalian cells. The formation of auto-
phagosomes critically depends on two
ubiquitin-like conjugation systems (Glick
et al., 2010 and references therein). The
first system depends on a protein com-
plex of Atg5, Atg12, and Atg16 to induce
autophagosomes. The second converts
the autophagy protein LC3-I/Atg8 into its
lipidated membrane-anchored LC3-II
form and depends on Atg7, Atg4B, and
Atg3. Although the cellular origin of auto-
phagosomal membranes is controversial,
several lines of evidence show an involve-
ment of ER, at least under some autoph-
agy-inducing conditions (Glick et al.,
2010), hinting at another possible analogy
to viral DMV formation. Indeed, the effects
of siRNA-mediated knockdown of spe-
cific Atgs, as well as the recruitment of
LC3 to viral RTCs, suggest a possible
involvement of autophagy in the formation
of DMVs for some viruses (reviewed in
Miller and Krijnse-Locker, 2008).
Mouse hepatitis virus (MHV) is harmless
to humans and is often used as a model
for severe acute respiratory syndrome co-
ronavirus (SARS-CoV) because it belongs
to the same family. Both viruses have
been shown to induce DMVs that are
thought to be ER derived (Knoops et al.,
2008; Ulasli et al., 2010). The DMVs of
MHV colocalize with LC3, but Atg5 was
shown to be dispensable for MHV infec-
tion in mice, indicating that only part ofthe autophagy machinery is involved in
infection (Zhao et al., 2007).
Inmost cells, the ER is a relatively abun-
dant source of membrane that is spread
throughout the cytoplasm. The ER is
dynamic and exerts many functions,
among which are the synthesis, translo-
cation, and transport of membrane and
secreted proteins. It is equipped with a
collection of chaperones that assist in
the proper folding of newly synthesized
proteins and a system that discards
proteins that fail to fold. The latter process
is called ER-associated degradation, or
ERAD. A crucial regulator of ERAD is the
membrane protein EDEM1 that controls
the degradation of mis-folded glycopro-
teins (Olivari and Molinari, 2007; Yoshida
and Tanaka, 2010). Work from the group
of Molinari suggested that the ERAD
activity of this protein may be regulated
by its relatively rapid turnover; it is sorted
from the ER into large vesicles, so-called
EDEMosomes that eventually fuse, in an
Atg5-dependent manner, with lysosomes
for degradation of their content, including
EDEM1 itself (Calı` et al., 2008). Another
striking similarity of EDEMosomes to au-
tophagy is that they are coated with non-
lipidated LC3-I, collectively suggesting
a possible crosstalk between these two
degradative pathways (Calı` et al., 2008).
In this issue of Cell Host & Microbe,
Reggiori and colleagues investigate the
origin of the MHV-induced DMVs and
the possible role of autophagy in MHV
replication. They show that LC3 localizes
to and cosediments with fractions en-
riched in the viral RTCs. Surprisingly,
Atg7, which converts LC3-I into its lipi-
dated form LC3-II, is not necessary for
the formation of virally induced DMVs or
for infectivity. Instead, unlipidated LC3-I
cosediments with isolated DMVs, collec-
tively suggesting that DMV formation
depends on a pathway that is related to
but different from autophagy. The authors
then go on to show that two proteins of
the ERAD pathway, EDEM-1 and OS9,
colocalize with viral RTCs. Infection with
MHV induces a turnover of specific
proteins (EDEM-1 and p62, a marker of
autophagy) that is consistent with the
tuning of ERAD, rather than induction of
the autophagy pathway. They show that
the MHV DMVs share features of EDEMo-
somes such as ER origin, the absence
of conventional ER markers, recruitment
of EDEM1, and LC3-I, but not LC3-II orCell Host & MicrobLC3-GFP. Of interest, whereas siRNA-
mediated knockdown of EDEM1 and
OS9 does not seem to affect MHV infec-
tion, the autophagy marker LC3 is essen-
tial for an early step of theMHV replication
cycle. Based on their results, the authors
postulate that coronaviruses hijack the
machinery of EDEMosome formation for
the generation of DMVs (Reggiori et al.,
2010). They propose that viral nonstruc-
tural proteins associate with an unknown
EDEMosome cargo receptor that nor-
mally mediates the sorting of EDEMo-
somes from the ER. During infection, the
EDEMosomes may be stabilized to form
viral DMVs that are unable to fuse with
lysosomes.
The data by Reggiori and colleagues
provide a comprehensive explanation for
the previous observation that, although
LC3 is recruited to MHV RTCs, Atg5 is
not required for viral infection. The study
also raises several questions that might
be the subject of future work. Does MHV
convert EDEMosomes into DMVs, and if
so, how? EDEM1 has been shown to
concentrate into large 150 nm vesicles
(the coronavirus DMVs are  80–160nm)
that are ER derived and that are COPII
negative (Zuber et al., 2007). Whether
these have a double-membrane appear-
ance is not clear at present. If viruses
use degradative pathways for their repli-
cation, how do they avoid unwanted
degradation? Reggiori and colleagues
propose the intriguing model that corona-
viruses may hijack only part of the ERAD
machinery to effectively uncouple up-
stream components, for instance by
excluding the SNARE that mediates the
fusion between EDEMosomes and lyso-
somes.
In conclusion, the study by Reggiori
and colleagues presents yet another
example of viruses as ultimate opportun-
ists. Whereas cells fight to survive by
eliminating viruses via various mecha-
nisms such as degradation, autophagy,
and apoptosis, viruses use these cellular
mechanisms to facilitate their replication
cycles, obviously by blocking fatal steps
of these processes that would lead to viral
destruction or premature cell death.REFERENCES
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